![]() |
|
|
Vol. 25, Issue 11, 1304-1310, 1997
Division of Medicinal and Natural Products Chemistry, College of Pharmacy, The University of Iowa
| |
Abstract |
|---|
|
|
|---|
Hydroxysteroid (alcohol) sulfotransferase STa catalyzes the
3
-phosphoadenosine 5
-phosphosulfate-dependent
O-sulfonation of a diverse array of alcohols including
neutral hydroxysteroids. Many of the secondary alcohols that interact
with this sulfotransferase are the metabolic products of
stereoselective oxidation or reduction reactions. The role that the
stereochemistry of secondary alcohol substrates plays in the catalytic
efficiency of STa was investigated with a series of chiral benzylic
alcohols and the enantiomeric 3-hydroxyl-containing steroids,
androsterone and epiandrosterone. In the case of (R)-(+)-
and (S)-(
)-enantiomers of 2-methyl-1-phenyl-1-propanol and 1-phenyl-1-butanol, the effect of stereochemistry on the catalytic efficiency of STa was small (less than 2-fold in favor of
(R)-(+)-enantiomers). However, as the number of carbons in
the
-alkyl chain increased, the stereoselectivity for the sulfation
of enantiomers increased as well. The (R)-(+)-enantiomers
of 1-phenyl-1-pentanol, 1-phenyl-1-hexanol, and 1-phenyl-1-heptanol
were preferred as substrates over the (S)-(
)-enantiomers
with a 3-fold difference in catalytic efficiency. STa showed absolute
stereospecificity in the sulfation of the enantiomers of
1-phenyl-1-cyclohexylmethanol;
(R)-(+)-1-phenyl-1-cyclohexylmethanol was a substrate for
STa, while the (S)-(
)-enantiomer was a competitive inhibitor of the enzyme. Although a lower degree of stereoselectivity was observed with the 3-hydroxyl-containing steroids, androsterone and
epiandrosterone, results with these substrates were also consistent with the conclusion that the stereochemistry of secondary alcohols is
an important factor in the catalytic efficiency of STa.
| |
Introduction |
|---|
|
|
|---|
Conjugation to
form sulfuric acid esters is an important reaction in the metabolism of
many drugs and other xenobiotics, neurotransmitters, and hormones
(1-4). These biotransformations are catalyzed by sulfotransferases in
reactions that involve the transfer of a sulfuryl group from
3
-phosphoadenosine 5
-phosphosulfate
(PAPS)1 to acceptor
substrates, thereby producing products that are usually more water
soluble and often less toxic. Hydroxysteroid (alcohol) sulfotransferases catalyze the sulfation of many steroids (1, 5, 6) as
well as various other alcohols (7, 8). Benzylic alcohols are among the
many diverse substrates for mammalian sulfotransferases. These alcohols
are often found as intermediary metabolites obtained from cytochrome
P-450 monooxygenase-catalyzed reactions involving the stereoselective
oxidation of benzylic carbon atoms (9). Benzylic alcohols can also be
obtained through metabolic reduction of benzylic carbonyls (10-12) and
through the cytochrome P450- and epoxide hydrolase-mediated metabolism
of polycylic aromatic hydrocarbons (13), reactions that are also
stereoselective.
Although sulfation of alcohols often leads to less toxic and more
readily excreted metabolites, some sulfo-oxy metabolites of benzylic
and allylic alcohols are sufficiently electrophilic that they can
covalently bind to cellular macromolecules (14). Some examples of these
electrophilic metabolites include the sulfuric acid esters derived from
5-hydroxymethyl-chrysene (15), safrole (16), estragole (16),
7,12-dihydroxymethylbenz[a]anthracene (17), and
3,4-dihydroxy-3,4-dihydrocyclopenta [cd]pyrene (18). Because the
metabolic formation of benzylic alcohols is usually stereoselective,
the stereochemical aspects of the subsequent sulfation of these
intermediates may have important implications for the carcinogenicity
of these polycyclic aromatic hydrocarbons. Furthermore, a recent report
on the DNA-binding properties of the antiestrogen antitumor agent,
tamoxifen, also indicates that stereochemical considerations may be
important in the formation of
-hydroxytamoxifen, an allylic
secondary alcohol, and its subsequent sulfation to an electrophilic
sulfuric acid ester capable of forming DNA adducts (19).
As implied by the name, hydroxysteroids also represent a class of
chiral secondary alcohols that serve as substrates for hydroxysteroid (alcohol) sulfotransferases. Strott and co-workers have reported on the
isolation and cloning of two distinct sulfotransferases from the guinea
pig adrenal (20, 21) that catalyzed the stereospecific sulfation of
3
- and 3
-hydroxysteroids. These enzymes were the first
characterized sulfotransferases that demonstrated substrate specificity
based on the stereochemistry of a 3-hydroxyl group on a hydroxysteroid.
We have previously observed that one of the aryl (phenol) sulfotransferases, AST IV, displayed stereoselectivity, and in some cases absolute stereospecificity, in catalyzing the sulfation of benzylic alcohol substrates (22). Moreover, this stereoselectivity increased with the size of the alkyl substituent on the benzylic carbon. Phenol sulfotransferases have also been shown to stereoselectively catalyze the O-sulfonation of the phenolic groups in 4-hydroxypropranolol and terbutaline, molecules where the chiral center is remote from the site of sulfation (23). Although aryl sulfotransferases have shown a pronounced stereoselectivity for some benzylic alcohols, these enzymes have displayed limitations in their ability to use large polycyclic aromatic hydrocarbons as substrates (24).
In contrast to the observations with aryl sulfotransferases, several carcinogenic polycylic aromatic hydrocarbons that bear benzylic alcohol functional groups are good substrates for both rat and human hepatic hydroxysteroid (alcohol) sulfotransferases (25, 26). The major isoform of the enzyme in rat liver was specified as sulfotransferase a (STa) (26), and it has also been designated as rHSST2 (2) and rHSTa (27). Our previous structure-activity studies on STa have shown that the catalytic efficiency of the enzyme increases with the hydrophobicity of the benzylic alcohol substrate (8). Steric factors may also influence the specificity of STa because quantitative studies on a series of seven-carbon alcohols as substrates for STa revealed that the catalytic efficiencies with primary alcohols were from 3-fold to 8-fold higher than those with secondary alcohols, and catalytic efficiencies with tertiary alcohols were approximately 10-fold lower than those observed for secondary alcohols (8).
In addition to hydrophobic and steric factors, the stereochemistry of
chiral alcohols is a property that might influence the catalytic
efficiency of STa. Indeed, the catalytic efficiency of STa with
(R)-(
)-2-heptanol was 35% higher than with the
(S)-(+)-enantiomer of 2-heptanol, and this relatively small
difference was the first indication of stereoselectivity in the
sulfation of alcohols catalyzed by this enzyme (8). We now report on a
more extensive investigation of the stereoselectivity of STa.
| |
Materials and Methods |
|---|
|
|
|---|
Thin layer chromatography (TLC) was performed on 250 µm-thick
precoated silica gel GF plates (Analtech, Newark, DE). Purification by
flash chromatography was accomplished with silica gel (200-400 mesh,
60 Å) from Aldrich Chemical Co. (Milwaukee, WI). Androsterone (5
-androstan-3
-ol-17-one) and epiandrosterone
(5
-androstan-3
-ol-17-one) were purchased from Sigma Chemical Co.
(St. Louis, MO). (R)-(+)-1-phenyl-2-methyl-1-propanol, (S)-(
)-1-phenyl-2-methyl-1-propanol,
(R)-(+)-1-phenyl-1-butanol, (S)-(
)-1-phenyl-1-butanol,
(+)-B-chlorodiisopinocampheylborane [(+)-DIP-chloride],
(
)-B-chlorodiisopinocampheylborane [(
)-DIP-chloride], and diethanolamine were obtained from Aldrich. Optical rotations of all
benzylic alcohols were determined at 589 nm and at 25°C using a
Perkin-Elmer model 141 polarimeter. The specific rotations of the
commercially obtained benzylic alcohols were as follows: (R)-(+)-2-methyl-1-phenyl-1-propanol, +23° (c
0.02, C2H5OH);
(S)-(
)-2-methyl-1-phenyl-1-propanol,
25° (c
0.02, C2H5OH);
(R)-(+)-1-phenyl-1-butanol, +50.6° (c 0.02, CHCl3); (S)-(
)-1-phenyl-1-butanol,
49.2° (c 0.02, CHCl3). PAPS was
prepared according to a published procedure (28), and adenosine 3
,5
-diphosphate (PAP) was obtained from Sigma. Tetrahydrofuran was
freshly distilled from sodium metal using benzophenone ketyl as
indicator. All other chemicals, assay reagents, and buffer components
were obtained from commercial sources.
Synthesis of Racemic Benzylic Alcohols. Racemates of sec benzylic alcohols were synthesized by reduction of the appropriate alkyl phenyl ketones using the general procedure described by Nystrom and Brown (29). To a solution of lithium aluminum hydride (10 ml of a 1.0 M solution in diethyl ether) was added 1 g of the appropriate alkyl phenyl ketone in 5 ml of diethyl ether at a rate that produced a gentle reflux. The reaction mixture was refluxed for 1.5 hr. After cooling the reaction mixture to 0°C, water was added to decompose the excess lithium aluminum hydride. Following addition of 20 ml of 10% (v/v) sulfuric acid, the solution was extracted with diethyl ether (4 × 50 ml). The combined organic layers were evaporated to yield the crude benzylic alcohol, which was subsequently purified by flash column chromatography with hexane/ethyl acetate (8:2) as the mobile phase. Yields of 70-75% were obtained for each of the four racemic benzylic alcohols prepared by this procedure.
Synthesis of Chiral Benzylic Alcohols.
(R)-(+)-1-Phenyl-1-pentanol,
(S)-(
)-1-phenyl-1-pentanol,
(R)-(+)-1-phenyl-1-hexanol,
(S)-(
)-1-phenyl-1-hexanol,
(R)-(+)-1-phenyl-1-heptanol, (S)-(
)-1-phenyl-1-heptanol,
(R)-(+)-1-phenyl-1-cyclohexylmethanol, and
(S)-(
)-1-phenyl-1-cyclohexylmethanol were synthesized by asymmetric reduction of the corresponding alkyl phenyl ketones according to a previously published general procedure (30). All
glassware was oven-dried overnight before use. All operations were
carried out under an argon atmosphere. The appropriate alkyl phenyl
ketone (11.3 mmol) was added to a solution containing 3.62 g (11.3 mmol) of either (+)- or (
)-DIP-chloride in tetrahydrofuran (10 ml) at
25°C. A yellow color developed immediately, and the reaction was
allowed to proceed at
25°C for 11 hr. The volatiles were removed on
a rotary evaporator, and the
-pinene was removed by placing the
reaction product under reduced pressure (0.1 mmHg) overnight. The
residue was dissolved in diethyl ether (75 ml), and diethanolamine (2.2 equiv.) was added. The separated solid was filtered off after 2 hr and
washed twice with n-pentane (30 ml). The combined
diethylether and n-pentane filtrates were concentrated. The
product chiral alcohol was purified by flash column chromatography with
hexane/ethylacetate (9:1) as the mobile phase. Yields of 60-75% were
obtained for each of the eight chiral benzylic alcohols prepared by
this procedure.
Preparation of
-Methoxy-
-(trifluoromethyl)phenylacetic Acid
(MTPA) Esters of Chiral Secondary Benzylic Alcohols.
MTPA esters of product benzylic alcohols were prepared by mixing the
appropriate alcohol (1 mmol), (S)-(
)-MTPA (1 mmol), dicyclohexylcarbodiimide (1 mmol), and 4-dimethylaminopyridine (0.1 mmol) in methylene chloride (10 ml) and stirring overnight at room
temperature. The dicyclohexylurea that precipitated was removed by
filtration. The filtrate was washed successively with 50-ml portions of
0.5 N HCl, 2 N Na2CO3, and
brine. The crude product obtained after evaporation of the organic
layer was purified by flash column chromatography with hexane/ethyl
acetate (8:2) as the mobile phase. The NMR spectrum of the MTPA esters
derived from each of the racemic benzylic alcohols displayed two sets of signals due to the methoxy and benzylic methine protons, whereas each enantiomerically pure benzylic alcohol showed only a single set of
signals.
Synthesis of 1-Phenyl-1-pentanols.
Chiral 1-phenyl-1-pentanols were prepared from valerophenone. IR (KBr)
v = 3370 cm
1 (O-H stretch),
3080-3010 cm
1 (C-H stretch, aromatic),
2950-2860 cm
1 (C-H stretch, aliphatic),
1800-1590 cm
1 (C=C, aromatic), 1453 cm
1 (O-H bending); 1H-NMR
(CDCl3)
0.9 ppm (t, 3H,
-CH2CH3),
1.2-1.4 ppm (m, 4H, -CH2-CH2-CH3),
1.65-1.86 ppm [m, 2H, -CH(OH)-CH2-],
1.85 ppm (s, 1H, OH),
4.69 ppm [t, 1H,
-CH(OH)-],
7.2-7.38 ppm (m, 5H,
C6H5-); GC-MS m/z 164 (M+·), 107 (M-C4H9), 91 (C7H7+),
77 (C6H5+),
51 (77-C2H2). For
(S)-(
)-1-phenyl-1-pentanol:
[
]25D = -19.2°
(c 0.18, CH3OH) [lit.
20°, neat,
ee 100% (31)]. ee = 100% based on 1H-NMR
of MTPA ester. The MTPA ester of racemic 1-phenyl-1-pentanol displayed
two sets of signals due to methoxy (s,
3.41 and 3.51 ppm) and
benzylic methine protons (t,
5.84 and 5.91 ppm), whereas the MTPA
ester of (S)-(
)-1-phenyl-1-pentanol showed only a single set of signals at
3.41 and 5.91 ppm. For
(R)-(+)-1-phenyl-1-pentanol: [
]25D = +20.2°
(c 0.19, CH3OH) [lit. +20°, neat,
ee 100% (32); +40.3°, c 1.0, CHCl3,
ee 94% (33)]. ee = 100% based on 1H-NMR
of MTPA ester. The MTPA ester of (R)-(+)-1-phenyl-1-pentanol showed only a single set of signals at
3.51 and 5.84 ppm.
Synthesis of 1-Phenyl-1-hexanols.
Chiral 1-phenyl-1-hexanols were prepared from hexanophenone. IR (KBr)
v = 3378 cm
1 (O-H stretch),
3085-3020 cm
1 (C-H stretch, aromatic),
2951-2879 cm
1 (C-H stretch, aliphatic),
1950-1700 cm
1 (C=C, aromatic), 1454 cm
1 (O-H bending); 1H-NMR
(CDCl3)
0.8 ppm (t, 3H,
-CH2CH3),
1.22-1.49 ppm [m, 6H,
-(CH2)3-CH3],
1.58-1.88 ppm [m, 2H, -CH(OH)-CH2-],
1.75 ppm (s, 1H, OH),
4.61 ppm [t, 1H,
-CH(OH)-],
7.21-7.42 ppm (m, 5H,
C6H5-); GC-MS m/z 178 (M+
), 107 (M-C5H11), 91 (C7H7+),
77 (C6H5+),
51 (77-C2H2). For
(S)-(
)-1-phenyl-1-hexanol:
[
]25D = -16.3°
(c 0.23, CH3OH). ee = 100% based
on 1H-NMR of MTPA ester. The MTPA ester of
racemic 1-phenyl-1-hexanol displayed two sets of signals because of
methoxy (s,
3.40 and 3.49 ppm) and benzylic methine protons (t,
5.84 and 5.91 ppm), whereas the MTPA ester of
(S)-(
)-1-phenyl-1-hexanol showed only a single set of
signals at
3.40 and 5.91 ppm. For
(R)-(+)-1-phenyl-1-hexanol: [
]25D = +16°
(c 0.23, CH3OH) [lit. +34.6°,
c 0.9, CHCl3, ee 93% (33)]. ee = 100% based on 1H-NMR of MTPA ester. The MTPA
ester of (R)-(+)-1-phenyl-1-hexanol showed only a single set
of signals at
3.49 and 5.84 ppm.
Synthesis of 1-Phenyl-1-heptanol.
Chiral 1-phenyl-1-heptanols were prepared from heptanophenone. IR (KBr)
v = 3400 cm
1 (O-H stretch),
3085-3020 cm
1 (C-H stretch aromatic),
2950-2870 cm
1 (C-H stretch, aliphatic),
1900-1700 cm
1 (C=C, aromatic), 1450 cm
1 (O-H bending); 1H-NMR
(CDCl3)
0.8 ppm (t, 3H,
-CH2CH3),
1.22-1.49 ppm [m, 8H,
-(CH2)4-CH3],
1.58-1.88 ppm [m, 2H, -CH(OH)-CH2-],
1.7 ppm (s, 1H, OH),
4.61 ppm [t, 1H,
-CH(OH)-],
7.21-7.42 ppm (m, 5H,
C6H5-); GC-MS m/z 192 (M+
), 107 (M-C6H13), 91 (C7H7+),
77 (C6H5+),
51 (77-C2H2). For
(S)-(
)-1-phenyl-1-heptanol:
[
]25D = -12°
(c 0.058, CH3OH) [lit. -20.5, c 0.88, C2H5OH,
ee 99.5% (34)]. ee = 100% based on 1H-NMR
of MTPA ester. The MTPA ester of racemic 1-phenyl-1-heptanol displayed
two sets of signals because of methoxy (s,
3.41 and 3.5 ppm) and
benzylic methine protons (t,
5.84 and 5.91 ppm), whereas the MTPA
ester of (S)-(
)-1-phenyl-1-heptanol showed only a single
set of signals at
3.41 and 5.91 ppm. For
(R)-(+)-1-phenyl-1-heptanol: [
]25D = +12.1°
(c 0.05, CH3OH) [lit. +19.7,
c 1.7, C2H5OH,
ee 99.5% (34)]. ee = 100% based on 1H-NMR
of MTPA ester. The MTPA ester of (R)-(+)-1-phenyl-1-heptanol showed only a single set of signals at
3.5 and 5.84 ppm.
Synthesis of 1-Phenyl-1-cyclohexylmethanol.
The chiral 1-phenyl-1-cyclohexylmethanols were prepared from
cyclohexylphenyl ketone. IR (KBr) v = 3409 cm
1 (O-H stretch), 3100-3030
cm
1 (C-H stretch, aromatic), 2927-2850
cm
1 (C-H stretch, aliphatic), 1850-1600
cm
1 (C=C, aromatic), 1450 cm
1 (O-H bending); 1H-NMR
(CDCl3)
0.8-1.92 ppm [m, 12H, cyclohexyl
and -CH(OH)-],
4.31 ppm [d, 1H, -CH(OH)-],
7.21-7.39 ppm (m, 5H,
C6H5-); GC-MS m/z 190 (M+
), 107 (M-C6H11), 91 (C7H7+),
77 (C6H5+),
51 (77-C2H2). For
(S)-(
)-1-phenyl-1-cyclohexylmethanol:
[
]25D = -18.8°
(c 0.1, CH3OH) [lit. -18.5°,
c 10.3, ether (35)]. ee= 100% based on
1H-NMR of MTPA ester. The MTPA ester of racemic
1-phenyl-1-cyclohexylmethanol displayed two sets of signals due to
methoxy (s,
3.41 and 3.49 ppm) and benzylic methine protons (t,
5.56 and 5.65 ppm), whereas the MTPA ester of
(S)-(
)-1-phenyl-1-cyclohexylmethanol showed only a single
set of signals at
3.41 and 5.65 ppm. For (R)-(+)- 1-phenyl-1-cyclohexylmethanol:
[
]25D = +19.2°
(c 0.07, CH3OH). ee= 96% based on
1H-NMR of MTPA ester. The MTPA ester of
(R)-(+)-1-phenyl-1-cyclohexylmethanol showed a major single
set of signals at
3.49 and 5.56 ppm.
Purification of Hydroxysteroid (Alcohol) Sulfotransferase STa. STa was purified to apparent homogeneity from female Sprague Dawley rats (9-10 weeks of age), using a modification (8) of previously published procedures (26, 36). The enzyme was homogeneous by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with Coomassie Blue staining. Protein concentrations were determined using a modified Lowry procedure (37), with bovine serum albumin as standard.
Assay of Hydroxysteroid Sulfotransferase STa with Benzylic Alcohols. The various benzylic alcohols were evaluated as both substrates and inhibitors of purified STa using a published HPLC procedure for determination of the concentration of PAP formed in the reaction (38). Reaction mixtures of 0.03 ml total volume contained 0.25 M potassium phosphate buffer at pH 7.0, 8.3 mM 2-mercaptoethanol, 0.3 mM PAPS, and various concentrations of the alcohols in acetonitrile (final concentration of acetonitrile in the assay was no more than 5% v/v). Reactions were initiated by the addition of 1.0 µg of enzyme, incubated at 37°C for 10 min., and terminated by addition of 0.03 ml of methanol. The substrate-dependent concentration of PAP formed in the reaction was determined by HPLC. Linear standard curves relating HPLC peak areas to concentrations of PAP were determined daily. At least six different concentrations of each alcohol were assayed, and these included concentrations both greater than and less than the apparent Km values. The substrate concentrations used to determine the kinetic constants for the enantiomeric benzylic alcohols were as follows: 1-phenyl-2-methyl-1-propanols, 0.5-7.0 mM; 1-phenyl-1-butanols, 0.4-7.0 mM; 1-phenyl-1-pentanols, 0.25-4.0 mM; 1-phenyl-1-hexanols, 0.25-2.0 mM; 1-phenyl-1-heptanols, 0.15-2.0 mM; 1-phenyl-1-cyclohexylmethanol, 0.25-3.0 mM. Apparent Km and Vmax values are presented as ± the standard error obtained by non-linear least squares curve fitting (39) of the velocity data to the Michaelis-Menten equation. Values for kcat were calculated using the relative molecular mass for a subunit of STa, 33,124, as determined from the deduced amino acid sequence (40).
Calculation of Hydrophobicity Constants for Chiral Benzylic Alcohols. Partition coefficients for chiral benzylic alcohols were calculated using the ACD/LogP computer program from Advanced Chemistry Development Inc. (Ontario, Canada).
| |
Results |
|---|
|
|
|---|
Role of the Configuration of a Benzylic Alcohol in the Catalytic
Efficiency of STa.
STa was previously reported to show a small degree of stereoselectivity
(35%) for (R)-(
)-2-heptanol over
(S)-(+)-2-heptanol (8). Based on this observation, we have
now investigated the stereochemical preferences of this enzyme with a
series of chiral benzylic alcohols. The catalytic efficiency of STa
with each chiral benzylic alcohol was determined by examination of the
kcat/Km values.
As seen in table 1, the effect of
stereochemistry at the benzylic carbon on the kinetic constants for
sulfation catalyzed by STa was small for (S)-(
)- and
(R)-(+)-2-methyl-1-phenyl-1-propanol and
(S)-(
)- and (R)-(+)-1-phenyl-1-butanol
(1.3-fold and 1.6-fold, respectively). However, as the carbon number on
the n-alkyl side chain that was
to the benzylic hydroxyl
increased, the stereoselectivity increased to 3-fold, as seen in table
1. In the case of 1-phenyl-1-cyclohexylmethanol, STa catalyzed
stereospecific sulfation of the (R)-(+)-enantiomer; the
(S)-(
)-enantiomer of 1-phenyl-1-cyclohexylmethanol was not a substrate for the enzyme. Further investigation revealed that the
(S)-(
)-1-phenyl-1-cyclohexylmethanol was a competitive
inhibitor of the STa-catalyzed sulfation of p-butylbenzyl
alcohol (fig. 1).
|
|
Role of Hydrophobic Characteristics of Chiral Benzylic Alcohols in the Catalytic Efficiency of STa. In addition to the orientation of the benzylic hydroxyl with respect to the phenyl ring and a alkyl substituent on the benzylic carbon, the hydrophobicity of these benzylic alcohols contributed to their ability to serve as substrates for the sulfotransferase STa. Calculated values of log p for each of the benzylic alcohols are seen in table 1. Comparison of these log p values with the catalytic efficiency of STa for these substrates (kcat/Km) revealed that kcat/Km values generally increased in relation to increasing log p values. These data were consistent with a previous study on the effect of hydrophobicity of primary benzylic alcohols on their ability to serve as substrates for STa (8). The small decrease in the kcat/Km values for 1-phenyl-1-heptanol when compared with the kcat/Km values for 1-phenyl-1-hexanol was not in good agreement with its high lipophilic character. However, it suggested that the ability of chiral benzylic alcohols to serve as substrates for STa depended on both the overall hydrophobicity of the molecules and the differences between the steric interactions of each enantiomer with the active site of the enzyme.
Androsterone and Epiandrosterone.
Steroids with 3
and 3
-hydroxy groups represent another class of
chiral secondary alcohols that are substrates for STa. Thus, we
investigated the STa-catalyzed sulfation of androsterone
(3
-hydroxyl) and epiandrosterone (3
-hydroxyl) as model
hydroxysteroid substrates. Although both epiandrosterone and
androsterone showed substrate inhibition above 60 µM and 80 µM,
respectively, a higher maximum velocity was demonstrated for
epiandrosterone. This result indicated a small degree of
stereoselectivity with epiandrosterone as the preferred substrate for
STa (fig. 2).
|
| |
Discussion |
|---|
|
|
|---|
Hydroxysteroid (alcohol) sulfotransferase STa catalyzes the
sulfation of various benzylic alcohols and steroids (1-4). We have
shown previously that the hydrophobicity of a benzylic alcohol is a
major determinant of its ability to act as a substrate for the enzyme
(8). In the present study, we investigated both stereochemical and
steric interactions at the active site of STa through the use of
-alkyl-substituted chiral benzylic alcohols as model substrates.
Although the difference in the configuration of the benzylic carbon
will not affect the overall hydrophobic character of the two
enantiomers, steric interactions with the active site of the enzyme may
be affected. Thus, the enantioselectivity of STa may be one indication
of the steric constraints that define the binding of substrates and
inhibitors at the active site of the enzyme.
The results of our studies indicated that as the length of the
-alkyl chain on a chiral benzylic alcohol was increased, the extent
of stereoselectivity in the reaction catalyzed by STa also increased.
Moreover, the enzyme showed absolute stereospecificity for the
enantiomers of 1-phenyl-1-cyclohexylmethanol, wherein the
-alkyl
substituent was the sterically bulky cyclohexyl group. The
(R)-(+)-enantiomer of 1-phenyl-1-cyclohexylmethanol was a substrate for STa, while the (S)-(
)-enantiomer was a
competitive inhibitor of STa-catalyzed sulfation of
p-butylbenzyl alcohol. In addition, the apparent
Km value for
(R)-(+)-1-phenyl-1-cyclohexylmethanol was higher than would
be expected on the basis of a comparison with either
(R)-(+)-1-phenyl-1-hexanol or
(R)-(+)-1-phenyl-1-heptanol. The
Vmax value for
(R)-(+)-1-phenyl-1-cyclohexylmethanol was also significantly
different from that observed with (R)-(+)-1-phenyl-1-hexanol and (R)-(+)-1-phenyl-1-heptanol. Neither this 10-fold
decrease in Vmax nor the observed increase
in the apparent Km value was consistent
with the hydrophobic characteristics of these molecules. Thus, the
presence of an
-cyclohexyl substituent on the benzylic carbon caused
steric interactions to be much more important in the reaction. Our
results support the conclusion that a specific orientation of the
benzylic hydroxyl on the substrate must be achieved at the active site
of STa before catalysis occurs, and that steric factors may combine
with the stereochemical configuration of the substrate or inhibitor to
determine the catalytic efficiency of the enzyme. The stereoselectivity
observed with benzylic alcohols as substrates for STa was also seen
with the hydroxysteroids androsterone and epiandrosterone. The
structure of androsterone differs from epiandrosterone only in the
configuration of the 3-hydroxyl group, that is, an
-orientation for
androsterone and a
-orientation for epiandrosterone. Although these
hydroxysteroids exhibit a stereoselectivity that is similar to some of
the enantiomeric benzylic alcohols, they show a substrate inhibition at
higher concentrations that has not yet been observed with the
-substituted benzylic alcohols. This substrate inhibition resembles
that previously seen with dehydroepiandrosterone as substrate for STa
(8). In the case of
-alkyl-substituted benzylic alcohols,
concentrations approaching the limit of solubility for each substrate
did not yield any substrate inhibition.
These observations on substrate inhibition, as well as the relatively
low degree of stereoselectivity for androsterone and epiandrosterone
with rat hepatic STa, contrast with reports on two other
3-hydroxysteroid sulfotransferases that have been characterized in
the guinea pig (20, 21). Although a significant sequence identity of
approximately 65% was reported between the enzymes from guinea pig and
the rat hydroxysteroid sulfotransferase (20, 21), it is apparent that
the differences in protein sequence are sufficient to affect the
kinetics and specificity of the enzymes from the two species. Although
substrate inhibition was seen for 3-hydroxysteroid substrates of STa,
no such interactions were reported for either of the 3-hydroxysteroid
sulfotransferases from guinea pig (20, 21). Moreover, results obtained
by cloning and expressing the guinea pig 3
-hydroxysteroid
sulfotransferase in CHO-K1 cells indicated that this enzyme did not act
on 3
-hydroxyl groups (21). Thus, there are distinct differences in
specificity and kinetics between the hydroxysteroid sulfotransferases
present in guinea pig and rat.
Additional documentation of species differences in the degree of
stereoselectivity of hydroxysteroid sulfotransferases has been recently
provided by Glatt et al., who have reported that 1-(1-pyrenyl)ethanol was activated to a mutagen with higher
enantioselectivity by Salmonella strains that contained
human hydroxysteroid sulfotransferase than those that contained rat STa
(27). In both strains, the (R)-(+)-enantiomer was more
mutagenic than the (S)-(
)-enantiomer, and this difference
in mutagenicity was attributed to higher rates of sulfation (27). Thus,
although there is substantial homology between the amino acid sequences
(i.e. 76% overall similarity between human
hydroxysteroid sulfotransferase and rat STa), there are
differences in the magnitude of stereoselectivity displayed by the
hydroxysteroid sulfotransferases from these two species. Such
differences are likely to be based on relatively subtle differences in
steric interactions between enzyme and substrate at the active site
that give rise to selectivity for the binding of one enantiomer in the
proper orientation for sulfuryl transfer. Our findings with
(S)-(
)-1-phenyl-1-cyclohexylmethanol indicate that an
enantiomer that is not properly oriented for sulfuryl transfer in the
active site is nevertheless bound due to its hydrophobic
characteristics and can thus serve as a competitive inhibitor. A more
complete understanding of the reasons why interactions with specific
amino acids at the active site would give rise to the observed
stereospecificity will await futher elucidation of the structures of
the active sites of these sulfotransferases.
In summary, our results clearly indicate that the stereochemistry of a chiral benzylic alcohol is an important factor in its interaction with STa. In molecules with a large bulky substituent on the chiral benzylic carbon, STa shows a marked preference for one enantiomer as substrate. Therefore, both the effect of hydrophobicity of the molecule and the steric effects that are related to the substituents on the chiral benzylic carbon atom are important determinants of the type and efficiency of interactions that occur between STa and chiral benzylic alcohols. Such relationships between chemical structure and activity as substrates and inhibitors for STa may prove useful in explaining and predicting the interactions of this sulfotransferase with other xenobiotics, as well as with molecules of endogenous origin.
| |
Footnotes |
|---|
Received April 28, 1997; accepted July 22, 1997.
This investigation was supported by United States Public Health Service Grant CA38683 awarded by the National Cancer Institute, Department of Health and Human Services.
Send reprint requests to: Michael W. Duffel, Division of Medicinal and Natural Products Chemistry, College of Pharmacy, The University of Iowa, Iowa City, IA 52242.
| |
Abbreviations |
|---|
Abbreviations used are:
PAPS, 3
-phosphoadenosine 5
-phosphosulfate;
PAP, adenosine
3
,5
-diphosphate;
MTPA,
-methoxy-
-(trifluoromethyl)phenylacetic acid;
HPLC, high
performance liquid chromatography.
| |
References |
|---|
|
|
|---|
| 1. | C. A. Strott: Steroid sulfotransferases. Endocr. Rev. 17, 670-697 (1996)[Medline]. |
| 2. | R. Weinshilboum and D. Otterness: Sulfotransferase Enzymes. In "Handbook of Experimental Pharmacology" (F. C. Kauffman, ed.), vol. 112, pp. 45-78. Springer-Verlag, Berlin, 1994. |
| 3. | G. J. Mulder and W. B. Jakoby: Sulfation. In "Conjugation Reactions in Drug Metabolism" (G. J. Mulder, ed.), pp. 107-161. Taylor and Francis, New York, 1990. |
| 4. | J. A. Miller and Y.-J. Surh: Sulfonation in chemical carcinogenesis. In "Handbook of Experimental Pharmacology" (F. C. Kauffman, ed.), vol. 112, pp. 429-458. Springer-Verlag, Berlin, 1994. |
| 5. |
R. A. Ryan and
J. Carroll:
Studies on a 3 -hydroxysteroid sulfotransferase from rat liver.
Biochim. Biophys. Acta.
429,
391-401 (1976)[Medline].
|
| 6. | V. Luu-The, F. Bernier, and I. Dufort: Steroid sulfotransferases. J. Endocrinol. 150, S87-S97 (1996)[Abstract]. |
| 7. | E. S. Lyon, C. J. Marcus, J.-L. Wang, and W. B. Jakoby: Hydroxysteroid sulfotransferases. Methods Enzymol. 77, 206-213 (1981)[Medline]. |
| 8. | G. Chen, E. Banoglu, and M. W. Duffel: Influence of substrate structure on the catalytic efficiency of hydroxysteroid sulfotransferase STa in the sulfation of alcohols. Chem. Res. Toxicol. 9, 67-74 (1996)[Medline]. |
| 9. | W. F. Trager: Stereochemistry of cytochrome P-450 reactions. Drug Metab. Rev. 20, 489-496 (1989)[Medline]. |
| 10. | B. Wermuth: Aldo-keto reductases. In "Enzymology of Carbonyl Metabolism 2" (T. G. Flynn and H. Weimer, eds.), pp. 209-230. Alan R. Liss, New York, 1985. |
| 11. | J. M. Y. Wong, W. A. Mahon, W. Kalow, and T. Inaba: Carbonyl (phenone) reductase in human liver: structure-activity relationship among substrates. Drug Metab. Dispos. 20, 465-466 (1992)[Medline]. |
| 12. | O. A. Barski, K. H. Gabbay, C. E. Grimshaw, and K. M. Bohren: Mechanism of human aldehyde reductase: characterization of the active site pocket. Biochemistry 34, 11264-11275 (1995)[Medline]. |
| 13. | S. K. Yang: Stereoselectivity of cytochrome P-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. Biochem. Pharmacol. 37, 61-70 (1988)[Medline]. |
| 14. | J. A. Miller: Sulfonation in chemical carcinogenesis: history and present status. Chem. Biol. Interact. 92, 329-341 (1994)[Medline]. |
| 15. | H. Okuda, N. Nojima, N. Watanabe, and T. Watabe: Sulphotransferase-mediated activation of the carcinogen 5-hydroxymethylchrysene: species and sex differences in tissue distribution of the enzyme activity and a possible participation of hydroxysteroid sulfotransferases. Biochem. Pharmacol. 38, 3003-3009 (1989)[Medline]. |
| 16. |
E. C. Miller,
A. B. Swanson,
D. H. Philips,
T. L. Fletcher,
A. Liem, and
J. A. Miller:
Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Cancer Res.
43,
1124-1134 (1983) |
| 17. |
T. Watabe,
A. Hiratsuka, and
K. Ogura:
Sulfotransferase mediated covalent binding of the carcinogen 7,12-dihydroxymethylbenz[ ]anthracene to calf thymus DNA and its inhibition by glutathione transferase.
Carcinogenesis
8,
445-453 (1987) |
| 18. |
Y.-J. Surh,
H. Kwon, and
S. R. Tannenbaum:
Sulfotransferase-mediated activation of 4-hydroxy- and 3,4-dihydroxy-3,4-dihydrocyclopenta [c,d]pyrene, major metabolites of cyclopenta[c,d]pyrene.
Cancer Res.
53,
1017-1022 (1993) |
| 19. |
L. Dasaradhi and
S. Shibutani:
Identification of tamoxifen-DNA adducts formed by -sulfate tamoxifen and -acetoxytamoxifen.
Chem. Res. Toxicol.
10,
189-196 (1997)[Medline].
|
| 20. |
W. J. Driscoll,
B. M. Martin,
H.-C. Chen, and
C. A. Strott:
Isolation of two distinct 3-hydroxysteroid sulfotransferases from the guinea pig adrenal.
J. Biol. Chem.
268,
23496-23503 (1993) |
| 21. |
Y. C. Lee,
C.-S. Park, and
C. A. Strott:
Molecular cloning of a chiral-specific 3 -hydroxysteroid sulfotransferase.
J. Biol. Chem.
269,
15838-15845 (1994) |
| 22. | S. I. Rao and M. W. Duffel: Benzylic alcohols as stereospecific substrates and inhibitors for aryl sulfotransferase. Chirality 3, 104-111 (1991)[Medline]. |
| 23. | T. Walle, U. K. Walle, J. A. Shwed, K. R. Thornburg, C. H. Mathis, and G. R. Pesola: Human phenolsulfotransferase: chiral substrates and expression in Hep G2 cells. Chem. Biol. Interact. 92, 47-55 (1994)[Medline]. |
| 24. | S. I. Rao and M. W. Duffel: Inhibition of rat hepatic aryl sulphotransferase IV by dihydrodiol derivatives of benzo[a]pyrene and naphthalene. Xenobiotica 22, 247-255 (1992)[Medline]. |
| 25. |
H. R. Glatt,
A. Seidel,
R. G. Harvey, and
M. W. H. Coughtrie:
Activation of benzylic alcohols to mutagens by human hepatic sulfotransferases.
Mutagenesis
9,
553-557 (1994) |
| 26. | K. Ogura, T. Sohtome, A. Sugiyama, H. Okuda, A. Hiratsuka, and T. Watabe: Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes. Mol. Pharmacol. 37, 848-854 (1990)[Abstract]. |
| 27. | H. Glatt: Bioactivation of mutagens via sulfation. FASEB J. 11, 314-321 (1997)[Abstract]. |
| 28. |
R. D. Sekura:
Adenosine 3 -phosphate 5 -phosphosulfate.
Methods Enzymol.
77,
413-415 (1981).
|
| 29. | R. F. Nystrom and W. G. Brown: Reduction of organic compounds by lithium aluminum hydride: II. Carboxylic acids. J. Am. Chem. Soc. 69, 2548-2549 (1947). |
| 30. | J. Chandrasekharan, P. V. Ramachandran, and H. C. Brown: Diisopinocampheylchloroborane, a remarkably efficient chiral reducing agent for aromatic prochiral ketones. J. Org. Chem. 50, 5446-5448 (1985). |
| 31. | R. Noyori, I. Tomino, Y. Tanimoto, and M. Nishizawa: Rational designing of efficient chiral reducing agents. Highly enantioselective reduction of aromatic ketones by binaphthol-modified lithium aluminum hydride reagents. J. Am. Chem. Soc. 106, 6709-6716 (1984). |
| 32. | S. Itsuno, M. Nakano, K. Miyazaki, H. Masuda, K. Ito, A. Hirao, and S. Nakahama: Asymmetric synthesis using chirally modified borohydrides: Part 3. Enantioselective reduction of ketones and oxime ethers with reagents prepared from borane and chiral amino alcohols. J. Chem. Soc. (Perkin I) 2039-2044 (1985). |
| 33. | A. J. M. Janssen, A. J. H. Klunder, and B. Zwanenburg: Resolution of secondary alcohols by enzyme catalyzed transesterification in alkyl carboxylates as the solvent. Tetrahedron 47, 7645-7662 (1991). |
| 34. | K. Mori and R. Bernotas: Enzymatic preparation of the enantiomers of some 1-phenyl-1-alkanols. Tetrahedron 1, 87-96 (1990). |
| 35. | R. MacLeod, F. J. Welch, and H. S. Mosher: Asymmetric reductions: VII. The action of the Grignard reagent from (+)-1-chloro-2-methylbutane on a series of alkyl phenyl ketones. J. Am. Chem. Soc. 82, 876-880 (1960). |
| 36. | T. Watabe, K. Ogura, M. Satsukawa, H. Okuda, and A. Hiratsuka: Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chem. Biol. Interact. 92, 87-105 (1994)[Medline]. |
| 37. | A. Bensadoun and D. Weinstein: Assay of proteins in the presence of interfering materials. Anal. Biochem. 70, 241-250 (1976)[Medline]. |
| 38. | M. W. Duffel, T. P. Binder, and S. I. Rao: Assay of purified aryl sulfotransferase suitable for reactions yielding unstable sulfuric acid esters. Anal. Biochem. 183, 320-324 (1989)[Medline]. |
| 39. | F. W. Perrella: EZ-FIT: a practical curve-fitting microcomputer program for the analysis of enzyme kinetic data on IBM-PC compatible computers. Anal. Biochem. 174, 437-447 (1988)[Medline]. |
| 40. | K. Ogura, J. Kajita, H. Narihata, T. Watabe, S. Ozawa, K. Nagata, Y. Yamazoe, and R. Kato: cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochem. Biophys. Res. Commun. 166, 1494-1500 (1990)[Medline]. |
This article has been cited by other articles:
![]() |
T. I. Apak and M. W. Duffel INTERACTIONS OF THE STEREOISOMERS OF {alpha}-HYDROXYTAMOXIFEN WITH HUMAN HYDROXYSTEROID SULFOTRANSFERASE SULT2A1 AND RAT HYDROXYSTEROID SULFOTRANSFERASE STA Drug Metab. Dispos., December 1, 2004; 32(12): 1501 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Sheng and M. W. Duffel ENANTIOSELECTIVITY OF HUMAN HYDROXYSTEROID SULFOTRANSFERASE ST2A3 WITH NAPHTHYL-1-ETHANOLS Drug Metab. Dispos., June 1, 2003; 31(6): 697 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gidda, O. Miersch, A. Levitin, J. Schmidt, C. Wasternack, and L. Varin Biochemical and Molecular Characterization of a Hydroxyjasmonate Sulfotransferase from Arabidopsis thaliana J. Biol. Chem., May 9, 2003; 278(20): 17895 - 17900. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sugahara, T. G. Pai, M. Suiko, Y. Sakakibara, and M.-C. Liu Differential Roles of Human Monoamine (M)-Form and Simple Phenol (P)-Form Phenol Sulfotransferases in Drug Metabolism J. Biochem., February 1, 2003; 133(2): 259 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rouleau, F. Marsolais, M. Richard, L. Nicolle, B. Voigt, G. Adam, and L. Varin Inactivation of Brassinosteroid Biological Activity by a Salicylate-inducible Steroid Sulfotransferase from Brassica napus J. Biol. Chem., July 23, 1999; 274(30): 20925 - 20930. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||